Evaluate the Efficacy and Safety of TTYP01 Tablets in the Treatment of Acute Ischemic Stroke
Clinical trial NCT06648304 · COMPLETED
Trial details
- NCT number
- NCT06648304
- Sponsor
- Shanghai Auzone Biological Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2024-06-17
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.